Characterization of Pre-Existing Neutralizing Antibody to Human Adenovirus Types 5 and 49 and Simian Type 23 in Chinese Population

Prime-boost vaccination of mice and Rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates

(2021) Shengxue Luo et al.   Emerging Microbes & Infections

A Self-Biomineralized Novel Adenovirus Vectored COVID-19 Vaccine for Boosting Immunization of Mice

(2021) Shengxue Luo et al.   VIROLOGICA SINICA

A high infectious simian adenovirus type 23 vector based vaccine efficiently protects common marmosets against Zika virus infection

(2020) Shengxue Luo et al.   PLoS Neglected Tropical Diseases

Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”

(2020) Yuqian Yan et al.   VIROLOGICA SINICA

A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development

(2019) Shengxue Luo et al.   VIRUS RESEARCH

Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage

(2018) Kun Xu et al.   JOURNAL OF VIROLOGY

A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55

(2018) Tiantian Liu et al.   VACCINE

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes

(2018) Annette von Delft et al.   VACCINE

Seroprevalence of Neutralizing Antibodies to Human Adenovirus Type 4 and 7 in Healthy Populations From Southern China

(2018) Xianmiao Ye et al.   Frontiers in Microbiology

Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial

(2017) Jing-Xin Li et al.   Lancet Global Health

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators

(2017) Arthur Dyer et al.   Molecular Therapy-Oncolytics

Detection and Molecular Typing of Human Adenoviruses Associated with Respiratory Illnesses in Kerala

(2016) Asia Devi Thounaojam et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1

(2016) Tao Cheng et al.   VACCINE

Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells

(2014) Maarten Holkers et al.   METHODS

Protection of non-human primates against rabies with an adenovirus recombinant vaccine

(2014) Z.Q. Xiang et al.   VIROLOGY

Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China

(2014) Xiang Wang et al.   Emerging Microbes & Infections

Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults

(2013) Shujun Zhang et al.   JOURNAL OF MEDICAL VIROLOGY

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

(2013) Richard D Antrobus et al.   MOLECULAR THERAPY

Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines

(2013) Eric A. Weaver et al.   PLoS One

Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera

(2013) Bin Yu et al.   VIROLOGY

Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)

(2012) A. Duerr et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccination with Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses than Adenovirus Serotype 5 in Rhesus Monkeys

(2012) Jeffrey E. Teigler et al.   JOURNAL OF VIROLOGY

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

(2012) Matthew D. J. Dicks et al.   PLoS One

Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China

(2011) Caijun Sun et al.   VACCINE

Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys

(2010) Jonatan Ersching et al.   VIROLOGY

The Role of Adenovirus in Respiratory Tract Infections

(2010) Anjali N. Kunz et al.   Current Infectious Disease Reports

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

(2009) T. Christopher Mast et al.   VACCINE

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

(2008) M Juliana McElrath et al.   LANCET

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

(2008) Susan P Buchbinder et al.   LANCET